DRIO Utang jangka cendhak perusahaan DarioHealth Corp.

DarioHealth Corp. (DRIO) generates revenue through the sale of smart glucometers and subscriptions to health monitoring software. Short-term financial debt levels show a turning point driven by the implementation of AI coaching to combat hypertension and diabetes, as well as the transition to secure cloud storage. The current value of 0.00 reflects the company's actual liabilities with a maturity of up to one year.

Analyzing the short-term debt profile of DarioHealth Corp. (DRIO), an investor can observe the dynamics of liabilities maturing within one year, which is critical for digital therapeutics when scaling B2B contracts with Aetna and Sanofi. This metric aggregates current loans and borrowings, allowing for an assessment of liquidity risk and the extent to which the implementation pace of AI solutions depends on the availability of operational debt refinancing.